electroCore (ECOR) Shareholder's Equity Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -230.31% |
| Dec 31, 2025 | -122.65% |
| Sep 30, 2025 | -111.35% |
| Jun 30, 2025 | -90.30% |
| Mar 31, 2025 | -2.91% |
| Dec 31, 2024 | 1.37% |
| Sep 30, 2024 | -14.36% |
| Jun 30, 2024 | 62.40% |
| Mar 31, 2024 | -62.05% |
| Dec 31, 2023 | -56.44% |
| Sep 30, 2023 | -50.28% |
| Jun 30, 2023 | -74.00% |
| Mar 31, 2023 | -62.76% |
| Dec 31, 2022 | -53.38% |
| Sep 30, 2022 | -46.00% |
| Jun 30, 2022 | 10.39% |
| Mar 31, 2022 | 19.31% |
| Dec 31, 2021 | 55.00% |
| Sep 30, 2021 | 42.29% |
| Jun 30, 2021 | 14.27% |
| Mar 31, 2021 | 50.37% |
| Dec 31, 2020 | -5.03% |
| Sep 30, 2020 | -10.52% |
| Jun 30, 2020 | -48.41% |
| Mar 31, 2020 | -66.65% |
| Dec 31, 2019 | -62.38% |
| Sep 30, 2019 | -59.83% |
| Jun 30, 2019 | -55.08% |
| Mar 31, 2019 | 153.80% |
| Dec 31, 2018 | 173.98% |